Skip to Navigation Skip to Content
  • Diagnostics
  • About Abbott
Abbott
Menu Location
Alere is now Abbott
  • You are here
  • Location
  • iconAbout

    About

    Abbott is a world leader in rapid diagnostics at the point of care, with a focus on cardio metabolic disease, infectious disease and toxicology.

    Read More - About
    • Partnerships
    • Experience POCT Stories
    • Events
    • Abbott Locations
    • News Archive
    • Investors
    • Contacts (Africa)
    • Alere™ i Hospital Experience
  • iconViewpoints

    Viewpoints

    Point-of-care diagnostics is a growing and dynamic industry helping to improve clinical and economic outcomes globally. Discover a variety of expert viewpoints on new innovations, insights, and impacts that are shaping the future of diagnostics around the world.

    Read More - Viewpoints
    • What does the NHTSA data mean for the future of roadside testing?
    • Don't Take that Antibiotic. You Might Get. . .Fat?
    • Malaria - Plasmodium Knowlesi: The New Threat
    • What's the Value of Molecular Testing at the POC?
    • Considerations for Setting a THC Cut-Off to Detect Cannabis Use in Oral Fluid Screening
    • The Importance of Evidence-Based Medicine in Point-of-Care Testing
    • African First Ladies Mobilize to End Transmission of Mother-to-Child HIV and Syphilis
    • Allaying Employees' Concerns About Workplace Drug Testing
    • Antimicrobial Resistance: Getting Straight to the Point!
    • Overcoming the screening challenges of new psychoactive substances
    • Comprehensive Diabetes Patient Care Program Yields Measureable Results
    • Fighting the Growing Threat of Antimicrobial Resistance
    • Zika Virus: A Growing Public Health Threat
    • Progress in Total Analytical Error Reduction
    • Strengthening Referrals and Linkages in Swaziland
    • Designer Stimulant Testing: A Fast Moving Target
    • Left Behind in the Global Response to HIV
    • Eliminating Malaria in India
    • New Guidance for Physicians for Diagnosing C. diff
    • Clinicians Gather to Encourage Point-of-Care Testing in Latin America
    • Diagnostics at Davos: A Call to Deploy POCT to Address the Tolls of Antimicrobial Resistance
    • RSV. It's Not Just for Kids Anymore!
    • Improving Type 2 Diabetes and Hypertension Services in Honduras
    • The Global Threat of Drug-Resistant Tuberculosis - Are We Doing Enough?
    • Workplace Policies for Prescription Drugs
    • Diagnosis and Management of the Diabetes Epidemic in the Pacific Islands
    • Diagnostic Access in Africa: The Evolution of HIV Point-of-Care Testing in Uganda
    • The Benefits of Pre-Employment Drug Testing
    • The Expanded Role for Australian Community Pharmacy in Chronic Disease Management
    • Shifting Paradigms in Connectivity: How Knowledge Management Can Strengthen Point of Care Programs
    • "This Respiratory Season, FDA's Reclassification of Rapid Influenza Diagnostic Tests Can Contribute to Better Patient Outcomes"
    • Bringing "Health on Wheels" to At-Risk Teens in Cape Town
    • The Value of Random Drug Testing
    • Abbott and Alere have joined together bringing healthcare diagnostics to more people in more places around the world
  • iconProducts & Services

    Products & Services

    Abbott products give providers, physicians and patients access to the right information at the right time.

    Read More - Products & Services
    • Explore Product Lookup
    • Solutions
    • Cardiometabolic

      Cardiometabolic

      Our products and services include tests to assist in the diagnosis and management of many cardiometabolic factors and conditions.

      Read More - Cardiometabolic Back -
      • Coronary Heart Disease/ACS
      • Diabetes
      • Dyslipidemia
      • Heart Failure
      • Hyperglycemia
      • Oral Anticoagulation
      • Shortness of Breath
      • VTE
      • Patient Health Monitoring
    • Infectious Disease

      Infectious Disease

      Our products and services include tests to assist in the diagnosis and management of many infectious diseases.

      Read More - Infectious Disease Back -
      • C. difficile
      • Cryptosporidiosis
      • Dengue Fever
      • E. coli
      • Enterics
      • Epstein Barr Virus (EBV)
      • GI Parasites
      • Hepatitis
      • Hepatitis
      • Herpes Simplex Virus
      • HIV
      • Intestinal Inflammation
      • Legionnaire's Disease
      • Leptospira
      • Influenza (Flu)
      • Malaria
      • Mononucleosis
      • MRSA
      • Pneumonia
      • Ross River/Barmah Forest
      • RSV
      • Rubella
      • S. aureus
      • Strep A pharyngitis
      • Streptococcus pneumoniae
      • Syphilis
      • C-reactive Protein Diagnostic Tests
      • Tuberculosis
      • Other Infectious Disease
    • Toxicology

      Toxicology

      Broad drug and alcohol testing portfolio includes rapid analyzer-based tests, visual-read screening devices, laboratory tests, and immunoassay reagents.

      Read More - Toxicology Back -
      • Employers
      • Government
      • Hospitals
      • OEM
      • Roadside Drug Testing
    • Toxicology Products & Services

      Toxicology Products & Services

      Alere™ Toxicology offers drug testing products and services that are used in a multitude of settings such as hospitals, clinics, physician offices, criminal justice, workplace, rehabilitation, occupational health clinics, and home testing.

      Read More - Toxicology Products & Services Back -
      • Laboratory Drug Screen
      • Oral Fluid Drug Test
      • Urine Drug Test
    • Other

      Other

      Our innovative diagnostics provide reliable and actionable information that enables informed decision-making by healthcare professionals at the point-of-care.

      Read More - Other Back -
      • Clinical Immunology
      • Oncology
      • POCT Data Management Platform
      • Women's Health
    • Browse by Brand

      Browse by Brand

      Our rapid diagnostic products are changing how healthcare is delivered-extending diagnosis and health management from the lab, doctor's office and hospital into people's homes.

      Read More - Browse by Brand Back -
      • Abon
      • Afinion
      • Alere Actim
      • BinaxNOW
      • Cholestech LDX™
      • Alere Determine
      • Alere hCG
      • Alere NMP22
      • Alere PBP2a SA
      • Pima CD4
      • Alere q
      • Alere TestPack
      • Alere Toxicology
      • AegisPOC
      • Clearview
      • Alere Determine
      • NHS Health Checks
      • i-STAT System
      • iCup
      • ID NOW™
      • NycoCard
      • RALS®
      • Standard Diagnostics
      • TECHLAB
      • Wampole
      • Additional Brands
    • NHS Health Checks
    • Patient Learning Series
    • For Patients
  • iconSupport

    Support

    Connect with us.

    Read More - Support
    • Contact Us
    • Product Document Search
    • Product Document Search
    • Product Demos
    • Terms of Trade
    • IQCP Support Resources

      IQCP Support Resources

      The Clinical Laboratory Improvement Amendments (CLIA) program recently introduced the Individualized Quality Control Plan (IQCP) as a new quality control option for nonwaived testing. We are pleased to provide you with materials to support your IQCPs.

      Read More - IQCP Support Resources Back -
    • Laboratory Test Support Resources
    • HIPAA & Patient Information
    • Contacts (Africa)

      Contacts (Africa)

      Each territory in Africa is assigned to a specific Alere Business Manager who will have the responsibility to support you for all the essential commercial activities

      Read More - Contacts (Africa) Back -
      • Africa Business Development and Support Services
      • EABU - English East Africa
      • EWBU - English West Africa
      • NFBU & CABU
      • SABU - South Africa
      • ZABU - Southern Africa
  • iconCareers
  • iconContact Us
  • iconFrançais
  • iconPortuguês
  • Facebook
  • Twitter
  • Linkedin
  • YouTube
  • Facebook
  • Twitter
  • Linkedin
  • YouTube
  • Facebook
  • Twitter
  • Linkedin
  • YouTube
  • Facebook
  • Twitter
  • Linkedin
  • YouTube
  • Facebook
  • Twitter
  • Linkedin
  • YouTube
  • Facebook
  • Twitter
  • Linkedin
  • YouTube
  • Facebook
  • Twitter
  • Linkedin
  • YouTube
  • Facebook
  • Twitter
  • Linkedin
  • YouTube
  • Facebook
  • Twitter
  • Linkedin
  • YouTube
  • Facebook
  • Twitter
  • Linkedin
  • YouTube
  • Facebook
  • Twitter
  • Linkedin
  • YouTube
  • Facebook
  • Twitter
  • Linkedin
  • YouTube
  • Facebook
  • Twitter
  • Linkedin
  • YouTube
  • Facebook
  • Twitter
  • Linkedin
  • YouTube

Welcome.

Please select your country.

All Regions
  • Global
  • United States
  • Africa
  • Argentina
  • Australia
  • België / Belgique
  • Brasil
  • Canada
  • Česká republika
  • 中华人民共和国
  • Colombia
  • Denmark
  • Deutschland
  • España
  • France
  • India
  • Indonesia
  • Ireland
  • Italia
  • Japan
  • 대한민국
  • Malaysia
  • Nederland
  • New Zealand
  • Norge
  • Österreich
  • Portugal
  • Schweiz / Suisse
  • Suomi
  • Sverige
  • 臺灣
  • United Kingdom
  • Home
    • Viewpoints
    • What does the NHTSA data mean for the future of roadside testing?
    • Don't Take that Antibiotic. You Might Get. . .Fat?
    • Malaria - Plasmodium Knowlesi: The New Threat
    • What's the Value of Molecular Testing at the POC?
    • Considerations for Setting a THC Cut-Off to Detect Cannabis Use in Oral Fluid Screening
    • The Importance of Evidence-Based Medicine in Point-of-Care Testing
    • African First Ladies Mobilize to End Transmission of Mother-to-Child HIV and Syphilis
    • Allaying Employees' Concerns About Workplace Drug Testing
    • Antimicrobial Resistance: Getting Straight to the Point!
    • Overcoming the screening challenges of new psychoactive substances
    • Comprehensive Diabetes Patient Care Program Yields Measureable Results
    • Fighting the Growing Threat of Antimicrobial Resistance
    • Zika Virus: A Growing Public Health Threat
    • Progress in Total Analytical Error Reduction
    • Strengthening Referrals and Linkages in Swaziland
    • Designer Stimulant Testing: A Fast Moving Target
    • Left Behind in the Global Response to HIV
    • Eliminating Malaria in India
    • New Guidance for Physicians for Diagnosing C. diff
    • Clinicians Gather to Encourage Point-of-Care Testing in Latin America
    • Diagnostics at Davos: A Call to Deploy POCT to Address the Tolls of Antimicrobial Resistance
    • RSV. It's Not Just for Kids Anymore!
    • Improving Type 2 Diabetes and Hypertension Services in Honduras
    • The Global Threat of Drug-Resistant Tuberculosis - Are We Doing Enough?
    • Workplace Policies for Prescription Drugs
    • Diagnosis and Management of the Diabetes Epidemic in the Pacific Islands
    • Diagnostic Access in Africa: The Evolution of HIV Point-of-Care Testing in Uganda
    • The Benefits of Pre-Employment Drug Testing
    • The Expanded Role for Australian Community Pharmacy in Chronic Disease Management
    • Shifting Paradigms in Connectivity: How Knowledge Management Can Strengthen Point of Care Programs
    • "This Respiratory Season, FDA's Reclassification of Rapid Influenza Diagnostic Tests Can Contribute to Better Patient Outcomes"
    • Bringing "Health on Wheels" to At-Risk Teens in Cape Town
    • The Value of Random Drug Testing
    • Abbott and Alere have joined together bringing healthcare diagnostics to more people in more places around the world
  • Home
  • Viewpoints
Share
  • Facebook
  • Twitter
  • linkedIn
  • Pinterest
  • Email
Viewpoints

Viewpoints

impact 06/30/16

African First Ladies Mobilize to End Transmission of Mother-to-Child HIV and Syphilis

author
Zeina Henaine
Social Responsibility Ambassador
African First Ladies Mobilize to End Transmission of Mother-to-Child HIV and Syphilis

Organisation of African First Ladies Against HIV/AIDS (OAFLA) has launched an important initiative to reduce the spread of HIV/AIDS and syphilis in Africa by preventing mother-to-child transmission (MTCT) of these diseases.

As part of our commitment to expanding access to point-of-care diagnostics, Alere supports organizations on the ground that are doing extraordinary work to screen the world’s most vulnerable populations for serious infectious diseases. Alere is proud to partner with the Organisation of African First Ladies Against HIV/AIDS (OAFLA) on one such initiative to reduce the spread of HIV/AIDS and syphilis in Africa by preventing mother-to-child transmission (MTCT) of these diseases.

Organisation of African First Ladies Against HIV/AIDS (OAFLA)

Established in 2002 by 37 African First Ladies, OAFLA advocates for policies to eliminate HIV/AIDS, reduce maternal and child mortality and empower women and children throughout Africa. Since then, the First Ladies have used their position of influence to effect change and reduce health disparities in their own countries and across the continent. Among other achievements, OAFLA has made great strides towards increasing the number of young people who know their HIV status and on accelerating action on maternal neonatal and child health. OAFLA has demonstrated what can be accomplished when leaders come together to tackle global health challenges.

As OAFLA’s only private sector partner, Alere has donated 200,000 HIV/syphilis rapid tests to African countries to support the OAFLA initiative.

In 2015, Alere more than doubled its initial commitment, making it possible to reach another 500,000 pregnant women, infants, adolescents and other at-risk populations in Africa with testing and prevention services.

African First Ladies Mobilize to End Transmission of Mother-to-Child HIV and Syphilis

The African First Ladies are using their influence to support achieving the Global Fast Track 90-90-90 targets by 2020 and to address one of the region’s greatest needs in HIV and syphilis prevention – screening pregnant women. Alere is proud to support OAFLA in its efforts to improve maternal and infant health in Africa by providing a simple, easy-to-use platform for the simultaneous detection of HIV and syphilis, which can allow for the prevention of MTCT and for babies and their mothers to receive timely, life-saving treatment.

Our work with OAFLA is just one of many partnerships that Alere participates in to increase access to rapid diagnostic tests and to reduce disease burden in the most heavily affected communities. Such initiatives are crucial to translating diagnostic access into meaningful impact for people worldwide.

References
  1. UNAIDS. Fact Sheet 2015. November 2015.
  2. WHO/UNAIDS/UNICEF. Global HIV/AIDS Response: Epidemic update and health sector progress towards Universal Access 2011.
  3. CDC. Mother-to-Child Transmission of HIV and Syphilis Globally. November 2011. Available at: http://www.cdc.gov/winnablebattles/mother-to-childtransmission/. Accessed on April 11, 2016.
  • Point of care testing
  • Remote setting
  • HIV
  • Rapid diagnostics
  • Infectious Disease
  • AIDS
  • Syphilis
  • Email
  • Facebook
  • Twitter
  • linkedIn
  • Google+
  • Print

Related Articles

  • View all
  • Hide all
  • Bringing “Health on Wheels” to At-risk Teens in Cape Town

    impact

    Bringing “Health on Wheels” to At-risk Teens in Cape Town

    View Now

    October 12, 2017

  • This Respiratory Season, FDA’s Reclassification of Rapid Influenza Diagnostic Tests Can Contribute to Better Patient Outcomes

    insight

    This Respiratory Season, FDA’s Reclassification of Rapid Influenza Diagnostic Tests Can Contribute to Better Patient Outcomes

    View Now

    October 12, 2017

  • Shifting Paradigms in Connectivity: How Knowledge Management Can Strengthen Point of Care Programs

    insight

    Shifting Paradigms in Connectivity: How Knowledge Management Can Strengthen Point of Care Programs

    View Now

    July 19, 2017

  • Diagnostic Access in Africa: The Evolution of HIV Point-of-Care Testing in Uganda

    impact

    Diagnostic Access in Africa: The Evolution of HIV Point-of-Care Testing in Uganda

    View Now

    May 31, 2017

  • The Global Threat of Drug-Resistant Tuberculosis – Are We Doing Enough?

    insight

    The Global Threat of Drug-Resistant Tuberculosis – Are We Doing Enough?

    View Now

    March 20, 2017

  • RSV. It’s Not Just for Kids Anymore!

    innovation

    RSV. It’s Not Just for Kids Anymore!

    View Now

    March 20, 2017

  • Diagnostics at Davos: A Call to Deploy POCT to Address the Tolls of Antimicrobial Resistance

    insight

    Diagnostics at Davos: A Call to Deploy POCT to Address the Tolls of Antimicrobial Resistance

    View Now

    March 20, 2017

  • Clinicians Gather to Encourage Point-of-Care Testing in Latin America

    impact

    Clinicians Gather to Encourage Point-of-Care Testing in Latin America

    View Now

    January 23, 2017

  • Eliminating Malaria in India

    impact

    Eliminating Malaria in India

    View Now

    January 23, 2017

  • Left Behind in the Global Response to HIV

    insight

    Left Behind in the Global Response to HIV

    View Now

    November 14, 2016

  • Strengthening Referrals and Linkages in Swaziland

    impact

    Strengthening Referrals and Linkages in Swaziland

    View Now

    November 14, 2016

  • Zika Virus: A Growing Public Health Threat

    insight

    Zika Virus: A Growing Public Health Threat

    View Now

    September 29, 2016

  • Fighting the Growing Threat of Antimicrobial Resistance

    impact

    Fighting the Growing Threat of Antimicrobial Resistance

    View Now

    September 29, 2016

  • Comprehensive Diabetes Patient Care Program Yields Measureable Results

    impact

    Comprehensive Diabetes Patient Care Program Yields Measureable Results

    View Now

    08/12/16

  • Antimicrobial Resistance: Getting Straight to the Point! about Rapid CRP Testing in Primary Care

    impact

    Antimicrobial Resistance: Getting Straight to the Point! about Rapid CRP Testing in Primary Care

    View Now

    08/12/16

  • The Importance of Evidence-Based Medicine in Point-of-Care Testing

    innovation

    The Importance of Evidence-Based Medicine in Point-of-Care Testing

    View Now

    6/30/2016

  • Molecular 101. What’s the Value of Molecular Testing at the POC?

    insight

    Molecular 101. What’s the Value of Molecular Testing at the POC?

    View Now

    06/30/16

  • Malaria - Plasmodium Knowlesi: The New Threat

    insight

    Malaria - Plasmodium Knowlesi: The New Threat

    View Now

    06/30/16

  • Don’t Take that Antibiotic. You Might Get... Fat? The Overuse of Antibiotics Meets the Science of Healthy Microbiomes

    insight

    Don’t Take that Antibiotic. You Might Get... Fat? The Overuse of Antibiotics Meets the Science of Healthy Microbiomes

    View Now

    06/30/16

 

Select a Topic

  • Insight
  • Innovation
  • Impact

Featured Articles:

  • Abbott and Alere have joined together bringing healthcare diagnostics to more people in more places around the world
  • The Value of Random Drug Testing
  • Bringing “Health on Wheels” to At-risk Teens in Cape Town
  • This Respiratory Season, FDA’s Reclassification of Rapid Influenza Diagnostic Tests Can Contribute to Better Patient Outcomes
  • Shifting Paradigms in Connectivity: How Knowledge Management Can Strengthen Point of Care Programs
  • The Expanded Role for Australian Community Pharmacy in Chronic Disease Management

Sign Up for Email Updates




Please enter valid email address.

Please enter correct answer.

Thank you for signing up.

Stay informed

Sign up to receive valuable updates from Abbott.

Click here to sign up
  • About
    • Partnerships
    • Experience POCT Stories
    • Events
    • Abbott Locations
    • Contacts (Africa)
    • Alere™ i Hospital Experience
  • Viewpoints
  • Products & Services
    • Solutions
    • Cardiometabolic
    • Infectious Disease
    • Toxicology
    • Toxicology Products & Services
    • Other
    • Browse by Brand
    • NHS Health Checks
    • Patient Learning Series
    • For Patients
  • Support
    • Contact Us
    • Product Document Search
    • Product Document Search
    • Product Demos
    • Terms of Trade
    • IQCP Support Resources
    • Laboratory Test Support Resources
    • HIPAA & Patient Information
    • Contacts (Africa)
  • Careers

Explore more with Abbott

  • About Abbott
  • Abbott Diagnostics
  • TestTargetTreat.com
  • AlereToxicology.com
  • PTINR.com
  • AlereToxicology.co.uk
  • AlereHealthcareConnections.com
  • eScreen.com
  • AlereCoag.com

©2019 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage. Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy: US Citizens | Non-US Citizens. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement (last updated: May 2018) | California Transparency in Supply Chains Act | Declaration for California Compliance Law.

Not all products are available in all regions. Check with your local representative for availability in specific markets. For In Vitro Diagnostic Use Only. See CTI Sheets on pointofcare.abbott for complete product information.

Abbott - A Leader in Rapid Point-of-Care Diagnostics.

Based on your current location, the content on this page may not be relevant for your country.
Please click here to return to the homepage. Alternatively, click the X button to acknowledge and proceed.
Close

contact us
More
Info?